On twitter, Elon Musk mentioned that there’s “promising” brain activity post-procedure, and the patient is on a good recovery path.
The company’s objective is to link human brains with computers to address complex neurological conditions, entering a field where several competitors have already introduced similar devices.
Professor Anne Vanhoestenberghe from King’s College London emphasized the significance of this human trial for a medical device-producing company. She acknowledged that while many companies are working on innovative products, Neuralink joins a relatively small group that has implanted devices in humans.
However, she advised caution, highlighting that the true success of such endeavors can only be assessed over the long term. Despite Elon Musk’s knack for generating publicity, she stressed the need for a cautious approach.
In the broader landscape, other players, such as École Polytechnique Fédérale in Lausanne, Switzerland, have made strides by enabling a paralyzed individual to walk through brain and spine implants communicating thoughts wirelessly to his legs and feet, as published in a peer-reviewed journal in May 2023.
It’s worth noting that there’s no independent verification of Musk’s claims, and Neuralink hasn’t provided details about the procedure.
